Randomised controlled trial of an internet intervention to reduce psychostimulant use

Not Applicable

• Conditions: Psychostimulant use; Mental Health - Addiction

• Registration Number: ACTRN12611000947909
• Lead Sponsor: The Australian National University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-09-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

Use of illicit psychostimulants (e.g. meth/amphetamine, ecstasy, non-medical use of prescription psychostimulants) in the last three months; willing to be randomised to one of two study groups; access to the Internet; access to e-mail; informed consent

Exclusion Criteria

Currently receiving pharmacotherapy (e.g. methadone, naltrexone, buprenorphine) for any substance use disorder except nicotine replacement therapy; currently receiving any treatment for psychostimulant abuse/dependence; current or past diagnosis of schizophrenia or bipolar disorder.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
WHO ASSIST Amphetamine Type Stimulant scores.[Baseline, 3 and 6-months after randomisation.];Mean help-seeking intention / behaviour scores (Wilson, Deane, & Ciarrochi, 2005).[Baseline, 3 and 6 months after randomisation.];Percentage of participants who move from Precontemplation to Contemplation/Action stage, or from Contemplation to Action stage, based on Readiness to Change questionnaire scores (Rollnick, Heather, Gold, & Hall, 1992).[Baseline, 3 and 6 months after randomisation]

Secondary Outcome Measures

Name	Time	Method
Mean K10 scores (psychological distress).[Baseline, 3 and 6 months after randomisation.];Poly drug use (defined as the sum of ASSIST classes of drugs reported).[Baseline, 3 and 6 months after randomisation.];Days out of Role scores (Kessler & Frank, 1997).[Baseline, 3 and 6 months after randomisation.];Mean EUROHIS Quality of Life scores (Schmidt, Muhlan, & Power, 2005).[Baseline, 3 and 6 months after randomisation];Descriptive measures of completion and adherence (active group only) assessed as i) completion of post test surveys, ii) number of modules completed iii) satisfaction with intervention.<br>Satisfaction will be measured with the first 8 items from the client satisfaction questionnaire (4 point likert scales)[3 months after randomisation.]